LINC02576: A Potential Drug Target and Biomarker (G102724233)

Target Name: LINC02576

NCBI ID: G102724233

LINC02576

Other Name(s): LINC02576 variant X4 | long intergenic non-protein coding RNA 2576 | Long intergenic non-protein coding RNA 2576, transcript variant X4

LINC02576: A Potential Drug Target and Biomarker

LINC02576 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LINCRNA family, which is known for their role in regulating gene expression and cell function. LINC02576 has been identified as a potential drug target and biomarker due to its unique structure and function.

The LINC02576 protein is composed of 257 amino acid residues and has a calculated molecular weight of 31.1 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is highly expressed in the brain. It is also expressed in the placenta, which suggests a potential role in fetal development and growth.

One of the key features of LINC02576 is its ability to interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3. This interaction suggests that LINC02576 may play a role in modulating gene expression and cell function.

Additionally, LINC02576 has been shown to interact with several protein kinases, including SGK-3, Pyk2, and FAK. This interaction suggests that LINC02576 may be a target for these kinases and may play a role in modulating cellular signaling pathways.

The unique structure of LINC02576 also suggests that it may be a potential drug target. LINC02576 has a unique N-terminus that consists of a single amino acid residue, which is unusual for a protein of its size. This single amino acid residue is located at the N-terminus of the protein and is involved in its stability and localization to the nuclear envelope.

The structure and function of LINC02576 also suggest that it may be a potential biomarker for various diseases. The expression of LINC02576 is highly correlated with the expression of several genes that are involved in various cellular processes, including cell growth, apoptosis, and inflammation. This suggests that LINC02576 may be a useful biomarker for diseases that are characterized by inflammation or cellular dysfunction.

In conclusion, LINC02576 is a protein that has unique structure and function and has been identified as a potential drug target and biomarker. Further research is needed to fully understand the role of LINC02576 in cellular signaling pathways and to determine its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2576

The "LINC02576 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02576 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets